|By PR Newswire||
|April 11, 2014 09:52 AM EDT||
WHIPPANY, N.J., April 11, 2014 /PRNewswire/ -- Bayer HealthCare today announced it has launched an educational website for U.S. physicians about a rare, life-threatening condition called Chronic Thromboembolic Pulmonary Hypertension (CTEPH). The site – www.CTEPH.com – is designed to increase CTEPH disease awareness among healthcare professionals (HCPs) and educate them on proper CTEPH diagnosis and surgical treatment. An expert panel of CTEPH experts worked with Bayer to develop the content and direction of the website.
CTEPH is a rare form of pulmonary hypertension (PH) in which blood clots and thromboembolic occlusion of the pulmonary vessels leads to increased pressure in the pulmonary arteries. The treatment of choice for patients that have operable CTEPH is pulmonary endarterectomy (PEA), a potentially curative surgery that clears clots and scar material from the blood vessels of the lung.
"CTEPH.com will be a valuable resource for clinicians. Bringing together the latest in scientific literature and expert opinion, this unique educational tool will provide accurate and up-to-date information on the evaluation and appropriate management of patients with chronic thromboembolic pulmonary hypertension. I believe this will be a valuable information site for those healthcare providers caring for patients with this devastating form of pulmonary hypertension," said William R. Auger, MD, Professor of Clinical Medicine, Research Director, Pulmonary Thromboendarterectomy Program, University of California, San Diego.
Each year, in the US, about 600,000 persons have an acute PE, and it is estimated that there are between 500 and 2,500 new cases of CTEPH diagnosed each year. A diagnosis of CTEPH is often not correctly made in patients with PH, because they have no overt history of PE.
CTEPH symptoms can be nonspecific and indistinguishable from symptoms of other forms of PH, but, when properly diagnosed, is potentially curable with PEA. Every patient diagnosed with CTEPH should be evaluated by an expert CTEPH team, including a CTEPH physician and PEA surgeons, to assess their candidacy for PEA surgery.
"As a physician caring for many patients with CTEPH, I have personally seen how lack of knowledge of this condition can negatively affect patient care. This resource will have huge value in raising awareness and informing healthcare providers about CTEPH, which will, in turn, help patients," Richard Channick MD, Director, Pulmonary Hypertension and Thromboemdarterectomy Program, Massachusetts General Hospital.
About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 18.9 billion (2013), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Intended for U.S. media only
SOURCE Bayer Corporation
Dec. 10, 2016 11:30 AM EST Reads: 2,019
Dec. 10, 2016 11:00 AM EST Reads: 660
Dec. 10, 2016 11:00 AM EST Reads: 691
Dec. 10, 2016 11:00 AM EST Reads: 487
Dec. 10, 2016 11:00 AM EST Reads: 1,006
Dec. 10, 2016 10:45 AM EST Reads: 1,049
Dec. 10, 2016 10:30 AM EST Reads: 906
Dec. 10, 2016 10:15 AM EST Reads: 633
Dec. 10, 2016 10:00 AM EST Reads: 1,082
Dec. 10, 2016 09:45 AM EST Reads: 640
"Qosmos has launched L7Viewer, a network traffic analysis tool, so it analyzes all the traffic between the virtual machine and the data center and the virtual machine and the external world," stated Sebastien Synold, Product Line Manager at Qosmos, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Dec. 10, 2016 09:30 AM EST Reads: 1,090
Internet-of-Things discussions can end up either going down the consumer gadget rabbit hole or focused on the sort of data logging that industrial manufacturers have been doing forever. However, in fact, companies today are already using IoT data both to optimize their operational technology and to improve the experience of customer interactions in novel ways. In his session at @ThingsExpo, Gordon Haff, Red Hat Technology Evangelist, will share examples from a wide range of industries – includin...
Dec. 10, 2016 09:00 AM EST Reads: 1,784
Kubernetes is a new and revolutionary open-sourced system for managing containers across multiple hosts in a cluster. Ansible is a simple IT automation tool for just about any requirement for reproducible environments. In his session at @DevOpsSummit at 18th Cloud Expo, Patrick Galbraith, a principal engineer at HPE, discussed how to build a fully functional Kubernetes cluster on a number of virtual machines or bare-metal hosts. Also included will be a brief demonstration of running a Galera MyS...
Dec. 10, 2016 08:45 AM EST Reads: 5,481
The WebRTC Summit New York, to be held June 6-8, 2017, at the Javits Center in New York City, NY, announces that its Call for Papers is now open. Topics include all aspects of improving IT delivery by eliminating waste through automated business models leveraging cloud technologies. WebRTC Summit is co-located with 20th International Cloud Expo and @ThingsExpo. WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web co...
Dec. 10, 2016 08:30 AM EST Reads: 1,511
"We build IoT infrastructure products - when you have to integrate different devices, different systems and cloud you have to build an application to do that but we eliminate the need to build an application. Our products can integrate any device, any system, any cloud regardless of protocol," explained Peter Jung, Chief Product Officer at Pulzze Systems, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Dec. 10, 2016 08:15 AM EST Reads: 1,264